BlackRock Science Valuation
| BST Etf | USD 40.62 0.08 0.20% |
At this time, the entity appears to be overvalued. BlackRock Science Tech shows a prevailing Real Value of $37.65 per share. The current price of the entity is $40.62. Our model approximates the value of BlackRock Science Tech from analyzing the entity fundamentals such as shares outstanding of 33.68 M, and Shares Owned By Institutions of 18.53 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that BlackRock Science's price fluctuation is very steady at this time. Calculation of the real value of BlackRock Science Tech is based on 3 months time horizon. Increasing BlackRock Science's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
BlackRock Science's intrinsic value may or may not be the same as its current market price of 40.62, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 40.62 | Real 37.65 | Hype 40.43 | Naive 39.89 |
The intrinsic value of BlackRock Science's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence BlackRock Science's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of BlackRock Science Tech helps investors to forecast how BlackRock etf's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of BlackRock Science more accurately as focusing exclusively on BlackRock Science's fundamentals will not take into account other important factors: BlackRock Science Total Value Analysis
BlackRock Science Tech is currently projected to have company total value of 1 B with market capitalization of 1 B, debt of , and cash on hands of . Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the BlackRock Science fundamentals before making security assessment based on enterprise value of the companyBlackRock Science Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The newest return on assets of BlackRock implies not a very effective usage of assets in January.BlackRock Science Ownership Allocation
BlackRock Science holds a total of 33.68 Million outstanding shares. Almost 81.46 percent of BlackRock Science outstanding shares are held by general public with 0.01 (percent) owned by insiders and only 18.53 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the entity is less than the current market value, you may not be able to make money on it.About BlackRock Science Valuation
The etf valuation mechanism determines BlackRock Science's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of BlackRock Science Tech based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of BlackRock Science. We calculate exposure to BlackRock Science's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of BlackRock Science's related companies.Other Information on Investing in BlackRock Etf
BlackRock Science financial ratios help investors to determine whether BlackRock Etf is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BlackRock with respect to the benefits of owning BlackRock Science security.